LYB 004
Alternative Names: LYB-004Latest Information Update: 11 Jun 2024
At a glance
- Originator Luye Pharma Group
- Class Varicella vaccines; Viral vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Herpes zoster
Most Recent Events
- 02 Apr 2024 Guangzhou Patronus Biotech in collaboration with Yantai Patronus Biotech plans a phase I trial for Herpes zoster (In adults, In the elderly, Prevention) in Australia (IM) (NCT06335849)
- 02 Apr 2024 Preclinical trials in Herpes zoster in China (IM), before March 2024
- 27 Mar 2024 Phase-I clinical trials in Herpes zoster (Prevention) in Australia (IM) (NCT06335849)